| 000 | 01497 a2200373 4500 | ||
|---|---|---|---|
| 005 | 20250516191750.0 | ||
| 264 | 0 | _c20140407 | |
| 008 | 201404s 0 0 jpn d | ||
| 022 | _a0015-5691 | ||
| 024 | 7 |
_a10.1254/fpj.143.40 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aYoshizaki, Hiroyuki | |
| 245 | 0 | 0 |
_a[Pharmacological profile of human-type anti-CD20 antibody ofatumumab (Arzerra(®)) and its clinical study results]. _h[electronic resource] |
| 260 |
_bNihon yakurigaku zasshi. Folia pharmacologica Japonica _cJan 2014 |
||
| 300 |
_a40-3 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAntibodies, Monoclonal _xadministration & dosage |
| 650 | 0 | 4 | _aAntibodies, Monoclonal, Humanized |
| 650 | 0 | 4 |
_aAntibody-Dependent Cell Cytotoxicity _xdrug effects |
| 650 | 0 | 4 |
_aAntigens, CD20 _ximmunology |
| 650 | 0 | 4 |
_aAntineoplastic Agents _xadministration & dosage |
| 650 | 0 | 4 | _aClinical Trials, Phase I as Topic |
| 650 | 0 | 4 | _aClinical Trials, Phase II as Topic |
| 650 | 0 | 4 |
_aComplement System Proteins _ximmunology |
| 650 | 0 | 4 | _aDisease Models, Animal |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aJapan |
| 650 | 0 | 4 |
_aLeukemia, Lymphocytic, Chronic, B-Cell _xdrug therapy |
| 650 | 0 | 4 | _aRepublic of Korea |
| 700 | 1 | _aTomonari, Akira | |
| 773 | 0 |
_tNihon yakurigaku zasshi. Folia pharmacologica Japonica _gvol. 143 _gno. 1 _gp. 40-3 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1254/fpj.143.40 _zAvailable from publisher's website |
| 999 |
_c23444972 _d23444972 |
||